E-Cigarettes, Vaping Devices, and Acute Lung Injury.

MedStar author(s):
Citation: Respiratory Care. 65(5):713-718, 2020 May.PMID: 32345762Institution: MedStar Health Research InstituteForm of publication: Journal ArticleMedline article type(s): Journal ArticleSubject headings: *Acute Lung Injury/ep [Epidemiology] | *Electronic Nicotine Delivery Systems/sn [Statistics & Numerical Data] | *Vaping/ae [Adverse Effects] | Acute Lung Injury/et [Etiology] | Adolescent | Adult | Aged | Disease Outbreaks | Female | Hospitalization | Humans | Male | Middle Aged | United States/ep [Epidemiology] | Young AdultYear: 2020Local holdings: Available online from MWHC library: 2003 - 2008, Available in print through MWHC library: 1999 - 2008ISSN:
  • 0020-1324
Name of journal: Respiratory careAbstract: "E-cigarettes" are a class of consumer devices designed to deliver drugs, primarily nicotine or marijuana oils, to the lung by vaporization. Regulation of the devices in the United States is relatively minimal, and research on both epidemiology and potential toxicity has focused on nicotine devices. In 2019, an outbreak of an acute respiratory illness in the United States was traced back to the contamination of e-cigarette fluids with vitamin E acetate, which had been used to disguise the dilution of marijuana oils. The outbreak, termed "e-cigarette or vaping associated lung injury" by the U.S. Centers for Disease Control, was characterized by pulmonary infiltrates and hypoxia, which usually required hospitalization and, often, admission to ICUs. The syndrome sickened >2,600 people, mostly young men, and killed >50 people before it began to abate 6 months later. No current regulations exist to prevent a similar event with the same or different chemical contaminants. Absent such regulation, respiratory practitioners should be prepared to evaluate, identify, and treat future cases of acute lung toxicity from e-cigarettes. Copyright (c) 2020 by Daedalus Enterprises.All authors: Cobb NK, Solanki JNOriginally published: Respiratory Care. 65(5):713-718, 2020 May.Fiscal year: FY2020Digital Object Identifier: Date added to catalog: 2020-07-09
Holdings
Item type Current library Collection Call number Status Date due Barcode
Journal Article MedStar Authors Catalog Article 32345762 Available 32345762

Available online from MWHC library: 2003 - 2008, Available in print through MWHC library: 1999 - 2008

"E-cigarettes" are a class of consumer devices designed to deliver drugs, primarily nicotine or marijuana oils, to the lung by vaporization. Regulation of the devices in the United States is relatively minimal, and research on both epidemiology and potential toxicity has focused on nicotine devices. In 2019, an outbreak of an acute respiratory illness in the United States was traced back to the contamination of e-cigarette fluids with vitamin E acetate, which had been used to disguise the dilution of marijuana oils. The outbreak, termed "e-cigarette or vaping associated lung injury" by the U.S. Centers for Disease Control, was characterized by pulmonary infiltrates and hypoxia, which usually required hospitalization and, often, admission to ICUs. The syndrome sickened >2,600 people, mostly young men, and killed >50 people before it began to abate 6 months later. No current regulations exist to prevent a similar event with the same or different chemical contaminants. Absent such regulation, respiratory practitioners should be prepared to evaluate, identify, and treat future cases of acute lung toxicity from e-cigarettes. Copyright (c) 2020 by Daedalus Enterprises.

English

Powered by Koha